Who are the key players in the Actimmune Market Report 2026 market?

Major companies operating in the Actimmune Market Report 2026 market are Major companies operating in the actimmune market are Amgen Inc. Read More

What are the major opportunities in the Actimmune market? What are the strategies for the Actimmune market?

For detailed insights on the major opportunities and strategies in the Actimmune market, Read More

How does the Actimmune market relate to the overall economy and other similar markets?

For detailed insights on Actimmune's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Actimmune market growth? SWOT analysis of the Actimmune market.

For detailed insights on the key dynamics influencing the Actimmune market growth and SWOT analysis of the Actimmune industry, Read More

Actimmune Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Actimmune Market Report 2026

Name: Actimmune Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Actimmune Market Overview

• The Actimmune market growth in the historic period has been driven by lack of alternative therapies for cgd, proven efficacy of interferon gamma therapy

• Market expansion is supported by rising diagnosis of rare immune disorders, increased access to specialty immunology centers

• Growth Driver: Rising Incidence Of Infectious Diseases Driving Actimmune Market Growth

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Actimmune Market?

Actimmune refers to a brand name for the drug interferon gamma-1b, a synthetic version of a naturally occurring protein that helps regulate the immune system. It is used to treat chronic granulomatous disease (CGD) and severe, malignant osteopetrosis by boosting the immune system to fight infections and improve bone strength.

The main indications for actimmune are chronic granulomatous disease (CGD), severe malignant osteopetrosis, and others. Chronic Granulomatous Disease (CGD) is a rare, inherited immunodeficiency disorder characterized by the inability of certain white blood cells to kill specific bacteria and fungi, leading to recurrent infections and granuloma formation. Patient groups in this are pediatric, adult, and others. It is distributed by various channels such as hospital pharmacies, specialty pharmacies, and online pharmacies, facilitating broad accessibility to the medication.

Actimmune Market Global Report 2026 Market Report bar graph

What Is The Actimmune Market Size and Share 2026?

The growth in the historic period can be attributed to lack of alternative therapies for cgd, proven efficacy of interferon gamma therapy, orphan drug support policies, specialist immunology adoption, improved survival outcomes.

What Is The Actimmune Market Growth Forecast?

The growth in the forecast period can be attributed to rising diagnosis of rare immune disorders, increased access to specialty immunology centers, long term therapy adherence focus, supportive reimbursement frameworks, continued orphan drug investment. Major trends in the forecast period include growing use in rare immunodeficiency disorders, increased focus on immune modulation therapies, expansion of long term immune support treatments, improved management of chronic granulomatous disease, rising adoption in specialized immunology care.

Book your 30 minutes free consultation with our research experts

Global Actimmune Market Segmentation

1) By Indication: Chronic Granulomatous Disease (CGD), Severe Malignant Osteopetrosis, Other Indications

2) By Patient Group: Pediatric, Adult, Other Patient Groups

3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

What Are The Drivers Of The Actimmune Market?

The rising incidence of infectious diseases is expected to propel the growth of the actimmune market going forward. Infectious diseases are illnesses caused by harmful microorganisms like bacteria, viruses, fungi, or parasites that invade the body, often spreading through direct contact, contaminated surfaces, or vectors, and can range in severity based on the pathogen and immune response. The rising incidence of infectious diseases is due to factors like population growth, poor sanitation, climate change, and the spread of new pathogens. Actimmune contributes to combating infectious diseases by enhancing the immune system's ability to identify and eliminate pathogens, including specific bacteria and viruses. It supports immune responses through the activation of macrophages and other immune cells, playing a crucial role in managing infections and reducing the severity of complications associated with immune deficiencies or chronic infections. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government department, tuberculosis (TB) cases in England rose by 10.7% in 2023, increasing from 4,380 in 2022 to 4,850. Therefore, the rising incidence of infectious diseases is driving the actimmune industry.

The rising prevalence of chronic diseases is expected to propel the growth of the actimmune markets going forward. Chronic diseases refer to long-lasting conditions that persist for a year or more and require ongoing medical attention or limit daily activities. The rising prevalence of chronic diseases is attributed to factors like aging, unhealthy lifestyles, environmental influences, genetics, and better diagnosis. Actimmune helps chronic diseases by modulating the immune response and reducing inflammation, making it effective in managing conditions such as chronic granulomatous disease and severe malignant osteopetrosis, where it enhances immune function and mitigates disease progression. For instance, in April 2024, according to Allergy UK, a UK-based national charity, more than 21 million people in the UK are affected by allergies, which became the most commonly reported chronic health condition in 2022, and projections indicate that by 2026, half of Europe's population will experience at least one allergy. Therefore, the rising prevalence of chronic diseases is driving the growth of actimmune industry.

Key Players In The Global Actimmune Market

Major companies operating in the actimmune market are Amgen Inc.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Actimmune Market?

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for a deal of $27.8 billion. Through this acquisition, Amgen Inc. aims to expand its portfolio in oncology and cardiovascular treatments while enhancing its biotechnology and drug development capabilities for future growth. Horizon Therapeutics plc is an Ireland-based biopharmaceutical company that specializes in actimmune, a treatment for rare diseases like chronic granulomatous disease (CGD) and osteopetrosis.

Regional Insights

North America was the largest region in the actimmune market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Actimmune Market?

The actimmune market consists of sales of products such as subcutaneous injections and single-use vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Actimmune Market Report 2026?

The actimmune market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the actimmune industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Actimmune Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Indication, Patient Group, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Amgen Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Actimmune Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Actimmune Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Actimmune Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Actimmune Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Use In Rare Immunodeficiency Disorders

4.2.2 Increased Focus On Immune Modulation Therapies

4.2.3 Expansion Of Long Term Immune Support Treatments

4.2.4 Improved Management Of Chronic Granulomatous Disease

4.2.5 Rising Adoption In Specialized Immunology Care

5. Actimmune Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Immunology Clinics

5.3 Pediatric Specialty Centers

5.4 Rare Disease Treatment Centers

5.5 Academic Research Hospitals

6. Actimmune Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Actimmune Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Actimmune PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Actimmune Market Size, Comparisons And Growth Rate Analysis

7.3. Global Actimmune Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Actimmune Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Actimmune Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Actimmune Market Segmentation

9.1. Global Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Granulomatous Disease (CGD), Severe Malignant Osteopetrosis, Other Indications

9.2. Global Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult, Other Patient Groups

9.3. Global Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies

10. Actimmune Market Regional And Country Analysis

10.1. Global Actimmune Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Actimmune Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Actimmune Market

11.1. Asia-Pacific Actimmune Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Actimmune Market

12.1. China Actimmune Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Actimmune Market

13.1. India Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Actimmune Market

14.1. Japan Actimmune Market Overview

14.2. Japan Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Actimmune Market

15.1. Australia Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Actimmune Market

16.1. South Korea Actimmune Market Overview

16.2. South Korea Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Actimmune Market

17.1. Western Europe Actimmune Market Overview

17.2. Western Europe Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Actimmune Market

18.1. UK Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Actimmune Market

19.1. Germany Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Actimmune Market

20.1. France Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Actimmune Market

21.1. Eastern Europe Actimmune Market Overview

21.2. Eastern Europe Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Actimmune Market

22.1. North America Actimmune Market Overview

22.2. North America Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Actimmune Market

23.1. USA Actimmune Market Overview

23.2. USA Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Actimmune Market

24.1. Canada Actimmune Market Overview

24.2. Canada Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Actimmune Market

25.1. South America Actimmune Market Overview

25.2. South America Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Actimmune Market

26.1. Middle East Actimmune Market Overview

26.2. Middle East Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Actimmune Market

27.1. Africa Actimmune Market Overview

27.2. Africa Actimmune Market, Segmentation By Indication, Segmentation By Patient Group, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Actimmune Market Regulatory and Investment Landscape

29. Actimmune Market Competitive Landscape And Company Profiles

29.1. Actimmune Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Actimmune Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Actimmune Market Company Profiles

29.3.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Actimmune Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Actimmune Market

32. Actimmune Market High Potential Countries, Segments and Strategies

32.1 Actimmune Market In 2030 - Countries Offering Most New Opportunities

32.2 Actimmune Market In 2030 - Segments Offering Most New Opportunities

32.3 Actimmune Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Actimmune Market, Overview Of Key Products - Product Examples

Table 2: Global Actimmune Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Actimmune Market, Supply Chain Analysis

Table 4: Global Actimmune Market, Major Raw Material Providers

Table 5: Global Actimmune Market, Major Resource Providers

Table 6: Global Actimmune Market, Major Manufacturers (Suppliers)

Table 7: Global Actimmune Market, Major Distributors And Channel Partners

Table 8: Global Actimmune Market, Key Technologies & Future Trends

Table 9: Global Actimmune Market, Major Trends

Table 10: Global Actimmune Market, Major End Users

Table 11: Global Actimmune Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Actimmune Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Actimmune Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Actimmune Market - TAM, US$ Billion, 2025

Table 15: Global Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Actimmune Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Actimmune Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Actimmune Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Actimmune Market - Company Scoring Matrix

Table 73: Amgen Inc. Financial Performance

Table 74: Global Actimmune Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Actimmune Market, Competitive Dashboard

Table 76: Global Actimmune Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 78: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Patient Group, 2025 – 2030

Table 79: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Actimmune Market, Overview Of Key Products - Product Examples

Figure 2: Global Actimmune Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Actimmune Market, Supply Chain Analysis

Figure 4: Global Actimmune Market, Major Raw Material Providers

Figure 5: Global Actimmune Market, Major Resource Providers

Figure 6: Global Actimmune Market, Major Manufacturers (Suppliers)

Figure 7: Global Actimmune Market, Major Distributors And Channel Partners

Figure 8: Global Actimmune Market, Key Technologies & Future Trends

Figure 9: Global Actimmune Market, Major Trends

Figure 10: Global Actimmune Market, Major End Users

Figure 11: Global Actimmune Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Actimmune Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Actimmune Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Actimmune Market - TAM, US$ Billion, 2025

Figure 15: Global Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Actimmune Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Actimmune Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Actimmune Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Actimmune Market, Segmentation By Patient Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Actimmune Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Actimmune Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Actimmune Market - Company Scoring Matrix

Figure 73: Amgen Inc. Financial Performance

Figure 74: Global Actimmune Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Actimmune Market, Competitive Dashboard

Figure 76: Global Actimmune Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 78: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Patient Group, 2025 – 2030

Figure 79: Global, Actimmune Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Autoimmune Disease Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables And Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), By E...

Veterinary Autoimmune Disease Therapeutics Market Report 2026 - Global Outlook – By Therapy Type (Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide), By Animal Type (Companion Anim...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Antibody Contract Manufacturing Market Report 2026 - Global Outlook – By Product (Monoclonal Antibodies, Polyclonal Antibodies, Other Products), By Source (Mammalian, Microbial), By Scale Of Operation (Preclinical, Clini...

Immune Health Supplements Market Report 2026 - Global Outlook – By Ingredients Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form (Soft Gels Or Capsules, Tablets...

Frequently Asked Questions

How big is the Actimmune Market?

The Actimmune market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

What is the Actimmune market growth?

The global Actimmune market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Who are the key players in Actimmune market?

Some Key Players in the Actimmune market Include, Amgen Inc. .

What is the anticipated growth trend for the Actimmune market?

Major trend in this market includes: nan. For further insights on this market. request a sample here

Which region has the most growth potential in the Actimmune market?

North America was the largest region in the actimmune market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actimmune market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.